Literature DB >> 1204506

Bufexamac: a review of its pharmacological properties and therapeutic efficacy in inflammatory dermatoses.

R N Brogden, R M Pinder, P R Sawyer, T M Speight, G S Avery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1204506     DOI： 10.2165/00003495-197510050-00005

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  13 in total

1.  A non-steroidal anti-inflammatory cream. A report from the General Practitioner Research Group.

Authors: 
Journal:  Practitioner       Date:  1975-05

2.  Bufexamac in the treatment of skin diseases in general practice.

Authors:  J C Valle-Jones
Journal:  Practitioner       Date:  1974-09

3.  [Bufexamac cream and ointment for the treatment of various dermatoses].

Authors:  G Achten; A Bourlond; E Haven; C M Lapière; J Piérard; H Reynaers
Journal:  Dermatologica       Date:  1973

4.  [p-butoxyphenylacethydroxamic acid in the treatment of rheumatic diseases].

Authors:  M Viara
Journal:  Clin Ter       Date:  1974-07-31

5.  [Clinical study of bufexamac ointment in gynecology and obstetrics].

Authors:  N Florence
Journal:  Brux Med       Date:  1972-03

6.  Pharmacological and clinical study of a new anti-inflammatory non-steroid topic, Bufexamac.

Authors:  N Rosselle; M H Faes; G Lambelin; R Roncucci; M J Simon
Journal:  J Belge Rhumatol Med Phys       Date:  1971 Mar-Apr

7.  Pharmacological studies of Bufexamac topically applied on the skin.

Authors:  G Lambelin; D Vassart-Thys; J Roba
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-10

8.  [Bufexamac, non-steroid anti-inflammatory agent utilizable locally in clinical dermatology].

Authors:  G Achten; A Bourlond; E Haven; C Lapiere; J Pierard; H Reynaers
Journal:  Arch Belg Dermatol Syphiligr       Date:  1970 Oct-Dec

9.  Arylacethydroxamic acids: a new class of potent non-steroid anti-inflammatory and analgesic substances.

Authors:  N P Buu-Hoï; G Lambelin; C Gillet; C Lepoivre; J Thiriaux; G Mees
Journal:  Nature       Date:  1966-08-13       Impact factor: 49.962

10.  Comparative study of bufexamac (Droxaryl) ointment and of its excipient on psoriasis cases: double-blind test.

Authors:  J Van der Meersch
Journal:  Curr Ther Res Clin Exp       Date:  1974-09
View more
  4 in total

1.  Integrated Analysis of Multiple Microarray Studies to Identify Core Gene-Expression Signatures Involved in Tubulointerstitial Injury in Diabetic Nephropathy.

Authors:  Huandi Zhou; Zhifen Yang; Lin Mu; Yonghong Shi
Journal:  Biomed Res Int       Date:  2022-05-10       Impact factor: 3.246

2.  Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema.

Authors:  H C Korting; M Schäfer-Korting; W Klövekorn; G Klövekorn; C Martin; P Laux
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Anti-inflammatory activity of hamamelis distillate applied topically to the skin. Influence of vehicle and dose.

Authors:  H C Korting; M Schäfer-Korting; H Hart; P Laux; M Schmid
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Bufexamac ameliorates LPS-induced acute lung injury in mice by targeting LTA4H.

Authors:  Qiang Xiao; Ningning Dong; Xue Yao; Dang Wu; Yanli Lu; Fei Mao; Jin Zhu; Jian Li; Jin Huang; Aifang Chen; Lu Huang; Xuehai Wang; Guangxiao Yang; Guangyuan He; Yong Xu; Weiqiang Lu
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.